Vice Chairman and HOD, Neuro Surgery and Neuro Spine, BLK-Max Super Speciality Hospital, New Delhi, India
Part 4 of 8 in Recent Advances in Spine and Neurosurgery
Deep Brain Stimulation for Parkinson's Disease: Timing, Targets and Cost
May 31, 2026
Levodopa and other dopaminergic drugs are effective initially in Parkinson's disease, but after 4 to 5 years the required dose escalates, side effects mount, and the medication effect starts to fade: that window is the ideal time to consider DBS, which can significantly reduce or eliminate the drug requirement and restore quality of life. The target is the subthalamic nucleus, localised through three complementary methods: anatomical targeting on preoperative MRI, microelectrode recording of characteristic brain wave patterns, and intraoperative clinical testing where the patient performs specific movements to confirm the electrode is producing the desired effect.
The all-inclusive package at BLK-Max (surgery, anaesthesia, device, medicines, testing and hospital stay) runs approximately USD 30,000 to 35,000. Non-rechargeable batteries need replacement every 5 to 7 years; rechargeable systems last around 15 years before that surgery is needed again, and newer devices allow remote settings adjustment via mobile. DBS is also used in dystonia, in intractable epilepsy via the anterior thalamus (70 to 80% effective), and, in selected and variable cases, in psychiatric conditions such as OCD.
This guide is based on a live Jivo Masterclass — Dr. Anil Kumar Kansal taught doctors across Africa on May 31, 2026.
FROM THE LIVE Q&A
Host (Varun, Jivo Healthcare)
There is a lot of public fear around spine and brain surgery. Can you share the actual complication rates so we can counsel patients accurately?
Dr. Anil Kumar Kansal
For spine surgery, major complications run around 2%, life-threatening complications around 0.5%, and neurological deficit around 1 to 1.5% — 98% of patients do well, 90% do very well, at a centre doing 400 to 500 spine surgeries a year. Patients should understand that surgery corrects the structural problem but can't always undo pre-existing nerve damage, so some residual tingling or numbness may persist even in a good outcome. For brain surgery, mortality is around 1 to 2% and total risk of neurological deficit is 5 to 7% at expert centres, with 93% of patients doing very well after tumour removal — the main caveat is that malignant tumours can recur despite surgery, since resection alone isn't curative and radiotherapy and chemotherapy are also required.
Book a Consultation with Dr. Anil Kumar Kansal
Book on WhatsAppOr message us on WhatsApp: +91 98182 98669
Frequently Asked Questions
How close are we to restoring function in patients with complete spinal cord injuries?▼
Complete spinal cord injuries will not result in complete neurological recovery, and some patients recover only minimally. What we can address is the secondary symptoms: pain and spasticity, managed with baclofen or morphine pumps, and dorsal cord stimulators, which can improve sensation and reduce spasticity, with some incomplete-injury patients regaining a degree of leg power combined with physiotherapy. If hand function is preserved, we train patients to manage daily life with their upper limbs and a wheelchair. But for complete injuries specifically, meaningful motor recovery is not something we can promise.
What is the role of stem cells in spinal cord injury management?▼
I conducted a study on this myself — we took stem cells from the iliac bone and implanted them at the injury site in around 20 patients. One patient showed some improvement, but it couldn't be separated from natural recovery under medication, and statistically we found no significant benefit. We discontinued the trial. Stem cell therapy for complete spinal cord injury is still not recommended anywhere in the world; for partial injuries there may be some benefit, but meaningful recovery from stem cells in complete injuries has not been demonstrated.
What are the current limitations of awake craniotomy and how are they being addressed?▼
Awake craniotomy, used for tumours near the motor cortex or speech areas, requires full patient cooperation throughout — some patients become agitated under partial sedation and we've had to convert to general anaesthesia. For international patients, a translator has to be present in the operating room the entire time, which adds another layer of difficulty. Personally I'm not very keen on it given how demanding it is for the patient; we now prefer using preoperative functional MRI to map eloquent areas and then operate under general anaesthesia while avoiding those mapped regions, which reduces the need for awake craniotomy in many cases.
I have a case of a hemangioma found on MRI in the cervical vertebral region. At what point does the patient benefit from surgery?▼
Small vertebral hemangiomas are benign and don't require treatment unless they cause problems. If it's a large hemangioma involving the pedicle, causing vertebral body destruction, or resulting in a fracture or neural compression, then decompression and spinal fixation are required. Share the MRI report with the Jivo team and we can assess based on size and extent.
As a leading neurosurgeon who has treated many international patients, what's your perspective on how direct doctor-to-doctor communication with African colleagues improves patient care?▼
Communication is key. I'd suggest two things: topic-oriented sessions on one specific subject at a time — lumbar spine surgery, or brain tumours — where everyone shares experience and problems and we learn from each other, since doctors from Africa and India face similar socioeconomic challenges. And continuous feedback after a patient returns home: the local doctor monitors recovery and communicates with us on repeat imaging and medication adjustments. That collaboration, by WhatsApp or email at any time, directly improves outcomes.
When is the right time to move a Parkinson's patient from medication to DBS?▼
Around 4 to 5 years after diagnosis, when the required medication dose is escalating, side effects are mounting, and the drug effect is starting to fade.
Which brain target does DBS use for Parkinson's disease and how is it localised?▼
The subthalamic nucleus, localised through anatomical targeting on preoperative MRI, microelectrode recording of characteristic brain wave patterns, and intraoperative clinical testing where the patient performs specific movements to confirm the electrode is placed correctly.
How much does DBS surgery cost?▼
The all-inclusive package at BLK-Max, covering surgery, anaesthesia, device, medicines, testing and hospital stay, runs approximately USD 30,000 to 35,000.
How often does the DBS battery need to be replaced?▼
Non-rechargeable batteries need replacement every 5 to 7 years. Rechargeable systems last around 15 years, and newer devices allow settings to be adjusted remotely by mobile.
Is DBS used for conditions other than Parkinson's disease?▼
Yes. It is also used in dystonia, in intractable epilepsy via the anterior thalamus with 70 to 80% effectiveness, and in select, variable cases of psychiatric conditions such as OCD.
In This Series: Recent Advances in Spine and Neurosurgery
- 1.Recent Advances in Spine and Neurosurgery
- 2.Minimally Invasive Spine Surgery: Percutaneous Discectomy, Kyphoplasty and Disc Replacement
- 3.Endoscopic Brain Surgery: Third Ventriculostomy and Colloid Cyst Removal
- 4.Deep Brain Stimulation for Parkinson's Disease: Timing, Targets and Cost
- 5.Trigeminal Neuralgia and Microvascular Decompression: A Cure for Facial Pain
- 6.Gamma Knife, Robotic Spine Surgery and the Limits of Current Technology
- 7.What Spine and Brain Surgery Complication Rates Actually Look Like
- 8.Complete Spinal Cord Injury: A Realistic Prognosis and What Can Still Be Treated